September 26, 2024,TOKYO, Japan & MALVERN, Pa., United States : Fujirebio today announced that its wholly-owned subsidiary Fujirebio Diagnostics, Inc. …
Canada’s Study Permit Cap: Indian Students Eye Alternative Destinations
Recent changes in study permits and caps on Master’s and PhD programs may lead to a decline in Indian students …
Aurion Biotech Launches Vyznova (neltependocel) in Japan for the Treatment of Bullous Keratopathy of the Cornea
September 25, 2024,TOKYO, Japan & Seattle, Cambridge, Mass., United States : Aurion Biotech, whose mission is to restore vision to …
Healing the Healers: Arya Vaidya Pharmacy Coimbatore Joins Innovative Ayurvedic Approach to Saving Ancient Trees
Mumbai, 23rd September, 2024: In a bold move that bridges millennia-old healing practices with pressing environmental concerns, The Arya Vaidya Pharmacy Coimbatore Ltd (AVP) has joined forces with a …
Cornea World Launches New Display Solutions at DIDAC India 2024
New Delhi, 24th September – Cornea World, a leading name in display solutions in India, has launched its newest range of products at DIDAC India 2024, the largest event for education and …
Malaysian giant Hartalega Continues to Flout India’s Bio Medical Waste Rules by Supplying Chlorinated Gloves Through Its Indian Subsidiary MUN Health Product
Mumbai, 23rd September’24: The Indian Rubber Gloves Manufacturers Association (IRGMA) has petitioned to the Union Minister of Environment, Forest & Climate Change Mr. Bhupender Yadav to …
Takeda Receives Approval for FRUZAQLA (fruquintinib) in Japan for the Treatment of Unresectable Advanced or Recurrent Colorectal Cancer
September 24, 2024,Osaka, Japan & Cambridge, Mass., United States : Takeda (TSE:4502/NYSE:TAK) today announced that it has received approval from …
Merz Aesthetics Announces the Launch of Ultherapy PRIME Platform as the Next Generation of Nonsurgical Skin Lifting Treatments
September 24, 2024,Raleigh, N.C., United States : Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the launch …
Debiopharm Recognizes Groundbreaking Japanese Cancer Research During the 83rd Annual Meeting of the Japanese Cancer Association
September 23, 2024,Lausanne, Switzerland : Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, aiming to establish tomorrow’s standard-of-care to cure cancer …
Quality CARE Expands into Tamil Nadu with Launch of New Hospital, KIMSHEALTH Nagercoil
KIMSHEALTH Nagercoil, a 210-bed quaternary & tertiary care hospital, is poised to become a healthcare hub for the region Chennai, …
